Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCVSCVS Health
FinDog View：Bullish
JNJJohnson & Johnson
FinDog View：Bullish
| Metric | CVS | JNJ |
|---|
| Close | 91.72 | 267.28 |
| Market Cap | $117B | $644B |
| 1M | −2.44% | +1.87% |
| P/E (TTM) | 24.4 | 30.6 |
| Forward P/E | 13.2 | 20.7 |
| P/E 5-Yr Percentile | 65 | 90 |
| P/S | 0.3 | 6.6 |
| P/B | 1.5 | 7.6 |
| Dividend Yield | 3.49% | 3.12% |
| Latest Quarter Revenue | $106B | $25.3B |
| Revenue YoY | +7.3% | +6.6% |
| Gross Margin | 44.5% | 68.2% |
| Latest Quarter EPS | 2.31 | 2.27 |
| Avg Post-Earnings Move | ±2.3% | ±0.6% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.91% | 1.25% |
| 90-Day Net Insider Buying | — | −$67.8M |
CVS · Revenue, Last 8 Quarters ($B)
JNJ · Revenue, Last 8 Quarters ($B)
